We are live on ! Find out more
MDT icon

Medtronic

2,027 hedge funds and large institutions have $136B invested in Medtronic in 2021 Q3 according to their latest regulatory filings, with 126 funds opening new positions, 939 increasing their positions, 675 reducing their positions, and 79 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more first-time investments, than exits

New positions opened: 126 | Existing positions closed: 79

39% more repeat investments, than reductions

Existing positions increased: 939 | Existing positions reduced: 675

1% more funds holding

Funds holding: 2,006 → 2,027 (+21)

8% more call options, than puts

Call options by funds: $1.09B | Put options by funds: $1.01B

0.6% less ownership

Funds ownership: 80.88% → 80.28% (-0.6%)

2% less funds holding in top 10

Funds holding in top 10: 56 → 55 (-1)

14% less capital inflows, than outflows

Capital inflows: $3.79B | Capital outflows: $4.4B

Holders
2,027
Holders Change
+21
Holders Change %
+1.05%
% of All Funds
35.36%
Holding in Top 10
55
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-1.79%
% of All Funds
0.96%
New
126
Increased
939
Reduced
675
Closed
79
Calls
$1.09B
Puts
$1.01B
Net Calls
+$77.1M
Net Calls Change
-$39.7M

MDT Hedge Fund Activity: Q3 2021 in Review

2,027 of the 5,733 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q3 2021, worth a combined $136B — up 0.4% from $135B a quarter earlier.

Buyers outnumbered sellers: 126 funds opened new MDT positions and 79 closed out — a net gain of 47 holders — while 939 added to existing stakes and 675 trimmed.

The largest buyer was Sustainable Growth Advisers, adding an estimated $250M. The largest seller was JP Morgan Chase, cutting an estimated $265M.

  • 2,027 institutional investors held Medtronic (MDT) as of Q3 2021, up from 2,006 in Q2 2021.
  • Funds reported $136B of Medtronic stock for Q3 2021, up 0.4% quarter-over-quarter.
  • 126 funds opened new Medtronic positions in Q3 2021 and 79 closed out, a net change of +47 holders.
  • The largest Medtronic buyer in Q3 2021 was Sustainable Growth Advisers, an estimated $250M added.
  • The largest Medtronic seller in Q3 2021 was JP Morgan Chase, an estimated $265M sold.

Based on aggregated 13F filings for Q3 2021.